Global efforts are ongoing to find ways to slow the spread of the novel coronavirus, as well as treat patients who have contracted the disease. There’s so much information about the processes companies are going through to develop vaccines, treatments and testing that it can be difficult to keep up with it all. The good news is every day that passes we are learning more about COVID-19 and how to deal with it as a society. For investors, looking at the stock market every day can be overwhelming no matter how much financial knowledge you have. We’ve identified some of the top companies that are moving forward with vaccines, treatments and testing of COVID-19 and what to think about them as an investor.
Leaders In Testing For COVID-19
Testing for COVID-19 has arguably been the most pressing need worldwide. For economies to open up to full capacity, we need to know people are safe. One way to do that is by having an abundance of tests available, and these companies are leading the way in this category:
- Roche Holdings
- Abbott Labs
- Eli Lilly
- Thermo Fisher Scientific
- Becton Dickinson
Companies With Promising Treatment Options
Treatments for COVID-19 may be the next most pressing thing needed globally. As new cases surface every day, reducing the death rate is critical. These companies have made major impacts with their treatment studies:
- Gilead Sciences
- Roche Holdings
- CSL Behring
Companies Actively Developing Vaccines For COVID-19
How the coronavirus is controlled globally in the long-term will largely depend on the vaccine development over the next several months. A good investment strategy is looking at these companies that are working hard to develop COVID-19 vaccines:
- Johnson & Johnson
- Inovio Pharmaceuticals
- CSL Behring
What To Look For As An Investor
So with all of these different companies making great strides in the fight against COVID-19, which ones offer the best investment opportunity? Like in many situations, the best long-term investments in the stock market come with a well-established company that has a strong foundation. As an investor, it’s easy to see the good things a company is doing right now related to COVID-19 efforts, but that doesn’t always make them a good long-term option. A basic rule of thumb is to always evaluate companies outside of what they are doing related to COVID-19 vaccines, treatments and testing. If you would still invest in them despite those efforts, then they will likely be a better long-term fit for your portfolio.
Stock Investing Info works with investors of all backgrounds regardless of their financial knowledge. COVID-19 is dominating the news today and it seems like the stock market is constantly fluctuating. Knowing which companies are making the right moves in the short-term and the long-term can make investors feel a little uneasy, so feel free to contact us at any time to learn more about your investment options and talk through the pros and cons of any given company.